Intended for healthcare professionals

News

Montelukast: Regulator reviewing asthma drug over concerns about mental health effects

BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q563 (Published 05 March 2024) Cite this as: BMJ 2024;384:q563